UNSPSC 51201633: Haemophilus influenzae b with diptheria and tetanus and acellular pertussis

This classification denotes a vaccine for a) a species of haemophilus found on the mucous membranes of humans and a variety of animals; b) A localized infection of mucous membranes or skin caused by toxigenic strains of corynebacterium diphtheriae; A disease caused by tetanospasmin, a powerful protein toxin produced by clostridium tetani; and d) A respiratory infection caused by bordetella pertussis.

UNSPSC 51201633 Haemophilus influenzae b with diptheria and tetanus and acellular pertussis (Commodity) covers vaccines combining protection against multiple bacterial pathogens in a single formulation. State and local health departments procure this vaccine for public health immunization programs, typically as part of routine childhood vaccination schedules or targeted disease-prevention initiatives. The code captures combination immunizations that bundle protection against Haemophilus influenzae type b, diphtheria, tetanus, and acellular pertussis in one dose. Issuing bodies are primarily state health departments and county health agencies responsible for maintaining vaccine supply for public clinics and community health programs.

Recent activity shows limited solicitation under this specific code. The Mississippi State Department of Health posted a sole source notice (3150006922, due August 3, 2026) for Yellow Fever Vaccine from Sanofi Pasteur, Inc., though that procurement aligns with the broader vaccine-procurement function rather than the specific multi-pathogen formulation named in the code itself. The notice invited objections to sole source classification by the due date and outlined the process by which substantiated challenges would trigger competitive bidding or review by the Public Procurement Review Board. Quantity, contract value, and term were not disclosed in the notice. Geographic activity is limited to Mississippi in the available record.